Cited by 155Smoking Behavior and CessationSubstance Abuse Treatment and OutcomesPrenatal Substance Exposure Effects

The DOI matches its Crossref record; 17 of the 18 references it cites were found in a registry or an index.

Mediating mechanisms for the impact of bupropion in smoking cessation treatment

Lerman, Caryn, Roth, David, Kaufmann, Vyga, Audrain, Janet, Hawk, Larry, Liu, Aiyi, Niaura, Ray, Epstein, Leonard·2002·Drug and Alcohol Dependence

DOI 10.1016/s0376-8716(02)00067-4

Open this paper in CoChat — free account

Abstract

Several studies have documented the effectiveness of bupropion for smoking cessation, yet little is known about the mechanisms by which it facilitates abstinence. In this placebo-controlled randomized trial. We examined whether bupropion's effects on cessation were mediated by changes in withdrawal and/or negative or positive affect (PA). Two hundred and fifty-one smokers received 10-week treatment with bupropion or placebo, plus behavioral counseling. Changes in affect and withdrawal symptoms from pre-quit to 1 week post quit were examined as mediating variables in structural equation models. Cotinine-verified 7-day point prevalence cessation rates at the end of treatment (8-weeks post quit date) were 48% for bupropion and 29% for placebo (P=0.001). There were significant treatment effects on withdrawal and negative affect (NA); however, only change in NA predicted cessation. In a path model, change in NA was a significant mediator of bupropion's effects on cessation. However, the proportion of variance accounted for by this mediator was small, suggesting that other unmeasured factors play an important role. Laboratory-based paradigms may be useful to identify other mediators of bupropion's effects, thereby pointing to mechanisms of effect that can be bolstered in future treatment studies.

Integrity signals

Registry

Crossref · 10.1016/s0376-8716(02)00067-4

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Development and validation of brief measures of positive and negative affect: The PANAS scales.
Watson, D., Clark, L. A., & Tellegen, A. (1988) · Journal of Personality and Social Psychology · doi:10.1037/0022-3514.54.6.1063 · Cited by 32,433
Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
LISREL 7 : user's reference guide
Jöreskog, K. G., & Sörbom, D. (1989) · Medical Entomology and Zoology · Cited by 6,783
Analysis of Incomplete Multivariate Data
Schafer, J. L. (1997) · doi:10.1201/9781439821862 · Cited by 6,012
Analysis of Incomplete Multivariate Data
Booth, D. E., & Schafer, J. L. (2000) · Technometrics · doi:10.2307/1271466 · Cited by 5,627
Multiple Imputation for Nonresponse in Surveys.
Lynn, P. J., & Rubin, D. B. (1988) · Journal of the Royal Statistical Society Series D (The Statistician) · doi:10.2307/2348774 · Cited by 2,330
Statistical Strategies for Small Sample Research
Hoyle, R. H. (1999) · Cited by 1,896
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation
Jorenby, D. E., Leischow, S. J., Nides, M. A., Rennard, S. I., Johnston, J. A., Hughes, A. R., Smith, S. S., Muramoto, M. L., Daughton, D. M., Doan, K., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903043400903 · Cited by 1,585
A Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation
Hurt, R. D., Sachs, D. P. L., Glover, E. D., Offord, K. P., Johnston, J. A., Dale, L. C., Khayrallah, M. A., Schroeder, D. R., Glover, P. N., Sullivan, C. R., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710233371703 · Cited by 1,262
Bupropion: a review of its mechanism of antidepressant activity.
Ascher, J. A., Cole, J. O., Colin, J. N., Feighner, J. P., Ferris, R. M., Fibiger, H. C., Golden, R. N., Martin, P., Potter, W. Z., & Richelson, E. (1995) · PubMed · Cited by 680

Show all 18 references

Sorted by citations

Antidepressants for smoking cessation
Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub5 · Cited by 1,352
Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report
Ziedonis, D., Hitsman, B., Beckham, J. C., Zvolensky, M., Adler, L. E., Audrain-McGovern, J., Breslau, N., Brown, R. A., George, T. P., Williams, J., et al. (2008) · Nicotine & Tobacco Research · doi:10.1080/14622200802443569 · Cited by 735
Co‐Morbidity of Smoking in Patients with Psychiatric and Substance Use Disorders
Kalman, D., Morissette, S. B., & George, T. P. (2005) · The American Journal on Addictions · doi:10.1080/10550490590924728 · Cited by 594
Antidepressants for smoking cessation
Hughes, J. R., Stead, L. F., & Lancaster, T. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub3 · Cited by 567
Cardiovascular Events Associated With Smoking Cessation Pharmacotherapies
Mills, E. J., Thorlund, K., Eapen, S., Wu, P., & Prochaska, J. J. (2013) · Circulation · doi:10.1161/circulationaha.113.003961 · Cited by 413
Relapse to smoking
Piasecki, T. M. (2006) · Clinical Psychology Review · doi:10.1016/j.cpr.2005.11.007 · Cited by 370
Pharmacological interventions for promoting smoking cessation during pregnancy
Coleman, T., Chamberlain, C., Davey, M.-A., Cooper, S. E., & Leonardi-Bee, J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010078.pub2 · Cited by 357
Confronting a Neglected Epidemic: Tobacco Cessation for Persons with Mental Illnesses and Substance Abuse Problems
Schroeder, S. A., & Morris, C. D. (2010) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.012809.103701 · Cited by 349
Antidepressants for smoking cessation
Hughes, J. R., Stead, L. F., Hartmann‐Boyce, J., Cahill, K., & Lancaster, T. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub4 · Cited by 357
Interventions for preventing weight gain after smoking cessation
Farley, A., Hájek, P., Lycett, D., & Aveyard, P. N. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006219.pub3 · Cited by 340
Efficacy of antidepressants in substance use disorders with and without comorbid depression
Torrens, M., Fonseca, F., Mateu-Codina, G., & Farré, M. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.09.004 · Cited by 272
Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent
Dwoskin, L. P., Rauhut, A. S., King‐Pospisil, K. A., & Bardo, M. T. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2006.00178.x · Cited by 259
Are there gender differences in smoking cessation, with and without bupropion? Pooled‐ and meta‐analyses of clinical trials of Bupropion SR
Scharf, D. M., & Shiffman, S. M. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00845.x · Cited by 255
Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat
Cryan, J. F., Bruijnzeel, A. W., Skjei, K. L., & Markou, A. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1445-7 · Cited by 223
Varenicline improves mood and cognition during smoking abstinence
Patterson, F., Jepson, C., Strasser, A. A., Loughead, J., Perkins, K. A., Gur, R. C., Frey, J. M., Siegel, S., & Lerman, C. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.028 · Cited by 222
Self-citation
Role of Functional Genetic Variation in the Dopamine D2 Receptor (DRD2) in Response to Bupropion and Nicotine Replacement Therapy for Tobacco Dependence: Results of Two Randomized Clinical Trials
Lerman, C. E., Jepson, C., Wileyto, E. P., Epstein, L. H., Rukstalis, M. R., Patterson, F., Kaufmann, V., Restine, S., Hawk, L. W., NIAURA, R. S., et al. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300861 · Cited by 197
Self-citation
The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial
Lerman, C. E., Wileyto, E. P., Patterson, F., Rukstalis, M. R., Audrain-McGovern, J. E., Restine, S., Shields, P. G., Kaufmann, V., Redden, D. T., Benowitz, N. L., et al. (2004) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500238 · Cited by 194
Self-citation
Pharmacological interventions for promoting smoking cessation during pregnancy
Claire, R., Chamberlain, C., Davey, M.-A., Cooper, S. E., Berlin, I., Leonardi-Bee, J., & Coleman, T. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010078.pub3 · Cited by 188
Toward Personalized Therapy for Smoking Cessation: A Randomized Placebo-controlled Trial of Bupropion
Patterson, F., Schnoll, R. A., Wileyto, E. P., Pinto, A. V., Epstein, L., Shields, P. G., Hawk, L. W., Tyndale, R. F., Benowitz, N. L., & Lerman, C. E. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.57 · Cited by 181
Self-citation
Pharmacogenetic investigation of smoking cessation treatment
Lerman, C. E., Shields, P. G., Wileyto, E. P., Audrain, J. E., Pinto, A., Hawk, L. W., Krishnan, S. S., NIAURA, R. S., & Epstein, L. H. (2002) · Pharmacogenetics · doi:10.1097/00008571-200211000-00007 · Cited by 180
Self-citation
Antidepressants for smoking cessation
Hughes, J., Stead, L., & Lancaster, T. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub2 · Cited by 175
Six-Month Trial of Bupropion With Contingency Management for Cocaine Dependence in a Methadone-Maintained Population
Poling, J. C., Oliveto, A. H., Petry, N. M., Sofuoglu, M., Gonsai, K., Gonzalez, G. M., Martell, B. A., & Kosten, T. R. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.2.219 · Cited by 168
Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial.
Lerman, C. E., Shields, P. G., Wileyto, E. P., Audrain, J. E., Hawk, L. W., Pinto, A., Kucharski, S., Krishnan, S. S., NIAURA, R. S., & Epstein, L. H. (2003) · Health Psychology · doi:10.1037/0278-6133.22.5.541 · Cited by 156
Self-citation
Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis
Thomas, K. H., Dalili, M. N., López-López, J. A., Keeney, E., Phillippo, D., Munafo, M. R., Stevenson, M., Caldwell, D. M., & Welton, N. J. (2021) · Health Technology Assessment · doi:10.3310/hta25590 · Cited by 163
Impulsivity and smoking relapse
Doran, N., Spring, B. J., McChargue, D. E., Pergadia, M. L., & Richmond, M. (2004) · Nicotine & Tobacco Research · doi:10.1080/14622200410001727939 · Cited by 163
Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice
Aubin, H., Luquiens, A., & Berlin, I. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12116 · Cited by 138
Nicotinic acetylcholine receptor β2 subunit gene implicated in a systems-based candidate gene study of smoking cessation
Conti, D. V., Lee, W., Li, D., Liu, J., Van Den Berg, D., Thomas, P. D., Bergen, A. W., Swan, G. E., Tyndale, R. F., Benowitz, N. L., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn181 · Cited by 136
Self-citation
Update on Pharmacologic Options for Smoking Cessation Treatment
Nides, M. A. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.01.016 · Cited by 130
Evidence-based treatments of addiction
O’Brien, C. P. (2008) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2008.0105 · Cited by 130
Current and emerging pharmacotherapies for treating tobacco dependence
Schnoll, R. A., & Lerman, C. E. (2006) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.11.3.429 · Cited by 117
Self-citation
Sex Differences in Varenicline Efficacy for Smoking Cessation: A Meta-Analysis
McKee, S. A., Smith, P. H., Kaufman, M., Mazure, C. M., & Weinberger, A. H. (2015) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntv207 · Cited by 119
Sex Differences in Smoking Cessation Pharmacotherapy Comparative Efficacy: A Network Meta-analysis
Smith, P. H., Weinberger, A. H., Zhang, J., Emme, E., Mazure, C. M., & McKee, S. A. (2016) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntw144 · Cited by 118
The role of negative affect in risk for early lapse among low distress tolerance smokers
Abrantes, A. M., Strong, D. R., Lejuez, C. W., Kahler, C. W., Carpenter, L. L., Price, L. H., Niaura, R., & Brown, R. A. (2008) · Addictive Behaviors · doi:10.1016/j.addbeh.2008.06.018 · Cited by 113
“All rights reserved. on smoking lapse may begin soon after attempts at cessation, as levels of negative affect assessed on quit date have been found to be predictive of smoking lapse (Lerman et al., 2002; McCarthy, Piasecki, Fiore, & Baker, 2006; Westmaas & Langsam, 2005).”
BackgroundSelf-citation
Using mediational models to explore the nature of tobacco motivation and tobacco treatment effects.
Piper, M. E., Federman, E. B., McCarthy, D. E., Bolt, D. M., Smith, S. S., Fiore, M. C., & Baker, T. B. (2008) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.117.1.94 · Cited by 105
Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation
David, S. P., Brown, R. A., Papandonatos, G. D., Kahler, C. W., Lloyd‐Richardson, E. E., Munafo, M. R., Shields, P. G., Lerman, C. E., Strong, D. R., McCaffery, J. M., et al. (2007) · Nicotine & Tobacco Research · doi:10.1080/14622200701382033 · Cited by 101
Self-citation
Psychological mediators of bupropion sustained‐release treatment for smoking cessation
McCarthy, D. E., Piasecki, T. M., Lawrence, D. L., Jorenby, D. E., Shiffman, S. S., & Baker, T. B. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02275.x · Cited by 99
Interventions for preventing weight gain after smoking cessation
Hartmann‐Boyce, J., Theodoulou, A., Farley, A., Hájek, P., Lycett, D., Jones, L. L., Kudlek, L., Heath, L., Hajizadeh, A., Schenkels, M., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006219.pub4 · Cited by 100
Modeling heaping in self‐reported cigarette counts
Wang, H., & Heitjan, D. F. (2008) · Statistics in Medicine · doi:10.1002/sim.3281 · Cited by 94
Psychometric properties of the Positive and Negative Affect Schedule (PANAS) in a heterogeneous sample of substance users
Serafini, K., Malin‐Mayor, B., Nich, C., Hunkele, K. A., & Carroll, K. M. (2016) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2015.1133632 · Cited by 92
Mechanisms Underlying the Comorbidity of Tobacco Use in Mental Health and Addictive Disorders
Morisano, D., Bacher, I., Audrain-McGovern, J. E., & George, T. P. (2009) · The Canadian Journal of Psychiatry · doi:10.1177/070674370905400603 · Cited by 95
Treating Tobacco Dependence: State of the Science and New Directions
Lerman, C. E., Patterson, F., & Berrettini, W. H. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.058 · Cited by 85
Self-citation
Pharmacotherapy and Pharmacogenetics of Nicotine Dependence
Berrettini, W. H., & Lerman, C. E. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.8.1441 · Cited by 85
Self-citation
Antidepressants for smoking cessation
Hajizadeh, A., Howes, S., Theodoulou, A., Klemperer, E., Hartmann-Boyce, J., Livingstone-Banks, J., & Lindson, N. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub6 · Cited by 84
Why two smoking cessation agents work better than one: Role of craving suppression.
Bolt, D. M., Piper, M. E., Theobald, W. E., & Baker, T. B. (2011) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0026366 · Cited by 84
Advancing the Understanding of Craving During Smoking Cessation Attempts: A Demonstration of the Time-Varying Effect Model
Lanza, S. T., Vasilenko, S. A., Liu, X., Li, R., & Piper, M. E. (2013) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntt128 · Cited by 83
Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell
Paterson, N. E., Balfour, D. J. K., & Markou, A. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05546.x · Cited by 80
REVIEW: New developments in the pharmacotherapy of cocaine abuse
Preti, A. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00061.x · Cited by 82
Increases in hyperactive-impulsive symptoms predict relapse among smokers in nicotine replacement therapy
Rukstalis, M., Jepson, C., Patterson, F., & Lerman, C. (2005) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2005.02.002 · Cited by 78
Self-citation
Effect of Bupropion on Depression Symptoms in a Smoking Cessation Clinical Trial.
Lerman, C. E., NIAURA, R. S., Collins, B. N., Wileyto, E. P., Audrain-McGovern, J. E., Pinto, A., Hawk, L. W., & Epstein, L. H. (2004) · Psychology of Addictive Behaviors · doi:10.1037/0893-164x.18.4.362 · Cited by 77
Self-citation
Non-nicotinic neuropharmacological strategies for nicotine dependence: beyond bupropion
Cryan, J. F., Gasparini, F., Heeke, G. V., & Markou, A. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02890-3 · Cited by 77
Impact of bupropion and cognitive–behavioral treatment for depression on positive affect, negative affect, and urges to smoke during cessation treatment
Strong, D. R., Kahler, C. W., Leventhal, A. M., Abrantes, A. M., Lloyd‐Richardson, E. E., NIAURA, R. S., & Brown, R. A. (2009) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntp111 · Cited by 75
Self-citation
A bupropion smoking cessation clinical trial for cancer patients
Schnoll, R. A., Martinez, E., Tatum, K. L., Weber, D. M., Kuzla, N., Glass, M., Ridge, J. A., Langer, C. J., Miyamoto, C. T., Wileyto, E. P., et al. (2010) · Cancer Causes & Control · doi:10.1007/s10552-010-9507-8 · Cited by 76
Treating nicotine use and dependence of pregnant and parenting smokers: An update
Melvin, C. L., & Gaffney, C. A. (2004) · Nicotine & Tobacco Research · doi:10.1080/14622200410001669231 · Cited by 74
Changes in food reward following smoking cessation: a pharmacogenetic investigation
Lerman, C. E., Berrettini, W. H., Pinto, A. G., Patterson, F., Crystal-Mansour, S., Wileyto, E. P., Restine, S., Leonard, D. G. B., Shields, P., & Epstein, L. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1823-9 · Cited by 71
Self-citation
Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling
Collins, B. N., Wileyto, E. P., Patterson, F., Rukstalis, M. R., Audrain-McGovern, J. E., Kaufmann, V., Pinto, A., Hawk, L. W., NIAURA, R. S., Epstein, L. H., et al. (2004) · Nicotine & Tobacco Research · doi:10.1080/14622200310001656830 · Cited by 70
Self-citation
Efficacy of pharmacotherapies for short-term smoking abstinance: A systematic review and meta-analysis
Mills, E. J., Wu, P., Spurden, D., Ebbert, J. O., & Wilson, K. R. (2009) · Harm Reduction Journal · doi:10.1186/1477-7517-6-25 · Cited by 69
Bupropion SR in Adolescents With Comorbid ADHD and Nicotine Dependence: A Pilot Study
Upadhyaya, H. P., Brady, K. T., & WANG, W. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200402000-00016 · Cited by 64
Bupropion for the treatment of nicotine withdrawal and craving
Mooney, M. E., & Sofuoglu, M. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.7.965 · Cited by 65
Mechanisms of change in extended cognitive behavioral treatment for tobacco dependence☆
Hendricks, P. S., Delucchi, K., & Hall, S. M. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.12.021 · Cited by 62
Pharmacogenetics and Nicotine Addiction Treatment
Munafo, M. R., Shields, A. E., Berrettini, W. H., Patterson, F., & Lerman, C. E. (2005) · Pharmacogenomics · doi:10.1517/14622416.6.3.211 · Cited by 60
Self-citation
Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome?
Murphy, M., Johnstone, E. C., Griffiths, S., Walton, R. T., David, S. P., NIAURA, R. S., Papandonatos, G. D., Shadel, W. G., Burkholder, G. J., Britt, D. M., et al. (2003) · Nicotine & Tobacco Research · doi:10.1080/14622200310001615295 · Cited by 60
Self-citation
The influence of depressive symptoms on smoking cessation among African Americans in a randomized trial of bupropion
Catley, D., Harris, K. J., Okuyemi, K. S., Mayo, M. S., Pankey, E., & Ahluwalia, J. S. (2005) · Nicotine & Tobacco Research · doi:10.1080/14622200500330118 · Cited by 59
A multi‐level analysis of non‐significant counseling effects in a randomized smoking cessation trial
McCarthy, D. E., Piasecki, T. M., Jorenby, D. E., Lawrence, D. L., Shiffman, S. S., & Baker, T. B. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.03089.x · Cited by 54
Protective effects of forced exercise against nicotine-induced anxiety, depression and cognition impairment in rat
Motaghinejad, M., Fatima, S., Karimian, M., & Ganji, S. (2015) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2014-0128 · Cited by 48
Functional Brain Changes in Response to Treatment of Internet Gaming Disorder
Han, D. H., Kim, S. M., & Renshaw, P. F. (2015) · Studies in neuroscience, psychology and behavioral economics · doi:10.1007/978-3-319-07242-5_5 · Cited by 48
Understanding the role of cessation fatigue in the smoking cessation process
Liu, X., Li, R., Lanza, S. T., Vasilenko, S. A., & Piper, M. E. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.07.025 · Cited by 47
Menstrual cycle phase at quit date and smoking abstinence at 6 weeks in an open label trial of bupropion
Mazure, C. M., Toll, B. A., McKee, S. A., Wu, R., & O’Malley, S. S. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.07.024 · Cited by 46
Recurrent event analysis of lapse and recovery in a smoking cessation clinical trial using bupropion
Wileyto, E. P., Patterson, F., NIAURA, R. S., Epstein, L. H., Brown, R. A., Audrain-McGovern, J. E., Hawk, L. W., & Lerman, C. E. (2005) · Nicotine & Tobacco Research · doi:10.1080/14622200500055673 · Cited by 46
Self-citation
Influence of fluoxetine on positive and negative affect in a clinic-based smoking cessation trial
Cook, J. W., Spring, B., McChargue, D. E., Borrelli, B., Hitsman, B., Niaura, R., Keuthen, N. J., & Kristeller, J. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1711-8 · Cited by 46
Self-citation
New Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?
Beard, E., Shahab, L., Cummings, D. M., Michie, S., & West, R. (2016) · CNS Drugs · doi:10.1007/s40263-016-0362-3 · Cited by 44
Pharmacogenetics of Drug Dependence: Role of Gene Variations in Susceptibility and Treatment
Khokhar, J. Y., Ferguson, C. S., Zhu, A. Z. X., & Tyndale, R. F. (2010) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105826 · Cited by 44
Combined effects of venlafaxine, nicotine replacement, and brief counseling on smoking cessation.
Cinciripini, P. M., Tsoh, J. Y., Wetter, D. W., Lam, C. Y., de Moor, C., Cinciripini, L. G., Baile, W. F., Anderson, C. B., & Minna, J. D. (2005) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.13.4.282 · Cited by 44
Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers
Schuit, E., Panagiotou, O. A., Munafo, M. R., Bennett, D., Bergen, A. W., & David, S. P. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011823.pub2 · Cited by 45
Retracted
Sleep Disturbance During Smoking Cessation: Withdrawal or Side Effect of Treatment?
Ashare, R. L., Lerman, C., Tyndale, R. F., Hawk, L. W., George, T. P., Cinciripini, P., & Schnoll, R. A. (2017) · Journal of Smoking Cessation · doi:10.1017/jsc.2016.11 · Cited by 42
Self-citation
Effects of varenicline and bupropion on cognitive processes among nicotine-deprived smokers.
Ashare, R. L., & McKee, S. A. (2011) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0025594 · Cited by 41
Subjective reactivity to the first cigarette of the day as a predictor of smoking relapse: A preliminary study
Toll, B. A., Schepis, T. S., O’Malley, S. S., McKee, S. A., & Krishnan‐Sarin, S. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.01.011 · Cited by 41
Benefits and Risks of Pharmacological Smoking Cessation Therapies in Chronic Obstructive Pulmonary Disease
Wagena, E. J., Zeegers, M. P., van Schayck, O. C. P., & Wouters, E. F. �. (2003) · Drug Safety · doi:10.2165/00002018-200326060-00002 · Cited by 42
Self-efficacy and acceptance of cravings to smoke underlie the effectiveness of quitline counseling for smoking cessation
Schuck, K., Otten, R., Kleinjan, M., Bricker, J. B., & Engels, R. C. M. E. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.06.033 · Cited by 40
Pharmacotherapy for smoking cessation: present and future
Aubin, H.-J., Karila, L., & Reynaud, M. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211796150837 · Cited by 39
No Evidence for a Major Role of Polymorphisms During Bupropion Treatment
Hu, J., Redden, D. T., Berrettini, W. H., Shields, P. G., Restine, S. L., Pinto, A. G., Lerman, C. E., & Allison, D. B. (2006) · Obesity · doi:10.1038/oby.2006.215 · Cited by 39
Self-citation
Behavioural and pharmacological mechanisms of bupropion's anti-smoking effects: Recent preclinical and clinical insights
Paterson, N. E. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.12.009 · Cited by 37
An efficient early phase 2 procedure to screen medications for efficacy in smoking cessation
Perkins, K. A., & Lerman, C. E. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3364-6 · Cited by 34
Self-citation
The effects of transcranial direct current stimulation compared to standard bupropion for the treatment of tobacco dependence: A randomized sham-controlled trial
Behnam, S. G., Mousavi, S. A., & Emamian, M. H. (2019) · European Psychiatry · doi:10.1016/j.eurpsy.2019.04.010 · Cited by 34
A placebo-controlled trial of modafinil for nicotine dependence
Schnoll, R. A., Wileyto, E. P., Pinto, A., Leone, F. T., Gariti, P., Siegel, S. J., Perkins, K. A., Dackis, C. A., Heitjan, D. F., Berrettini, W. H., et al. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.04.008 · Cited by 33
Self-citation
Beliefs and attitudes about bupropion: Implications for medication adherence and smoking cessation treatment.
Fucito, L. M., Toll, B. A., Salovey, P., & O’Malley, S. S. (2009) · Psychology of Addictive Behaviors · doi:10.1037/a0015695 · Cited by 33
Acute Effects of Aerobic Exercise on Affect and Smoking Craving in the Weeks Before and After a Cessation Attempt
Abrantes, A. M., Farris, S. G., Minami, H., Strong, D. R., Riebe, D. A., & Brown, R. A. (2017) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntx104 · Cited by 34
Bupropion SR for smoking cessation
West, R. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.4.533 · Cited by 36
“Off-Label” Usage of Testicular Self-Examination (TSE): Benefits Beyond Cancer Detection
Rovito, M. J., Leone, J. E., & Cavayero, C. T. (2015) · American Journal of Men s Health · doi:10.1177/1557988315584942 · Cited by 32
Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans
Sofuoglu, M., Herman, A. I., Mooney, M. E., & Waters, A. J. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1643-z · Cited by 32
Elevated positive mood: A mixed blessing for abstinence.
Doran, N., Spring, B. J., Borrelli, B., McChargue, D. E., Hitsman, B. L., NIAURA, R. S., & Hedeker, D. (2006) · Psychology of Addictive Behaviors · doi:10.1037/0893-164x.20.1.36 · Cited by 32
Self-citation
Incremental efficacy of adding bupropion to the nicotine patch for smoking cessation in smokers with a recent history of alcohol dependence: Results from a randomized, double-blind, placebo-controlled study
Kalman, D., Herz, L. R., Monti, P. M., Kahler, C. W., Mooney, M. E., Rodrigues, S., & O’Connor, K. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.03.005 · Cited by 31
Efficacy of Sequential Use of Fluoxetine for Smoking Cessation in Elevated Depressive Symptom Smokers
Brown, R. A., Abrantes, A. M., Strong, D. R., NIAURA, R. S., Kahler, C. W., Miller, I. W., & Price, L. H. (2013) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntt134 · Cited by 31
Self-citation
Reinforcing Effects of Smoking: More Than a Feeling
Lerman, C. E., & Audrain-McGovern, J. E. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.02.014 · Cited by 29
Self-citation
Effects of different nicotine replacement therapies on postcessation psychological responses
Strasser, A. A., Kaufmann, V., Jepson, C., Perkins, K. A., Pickworth, W. B., Wileyto, E. P., Rukstalis, M. R., Audrain-McGovern, J. E., & Lerman, C. E. (2004) · Addictive Behaviors · doi:10.1016/j.addbeh.2004.04.005 · Cited by 28
Self-citation
Bupropion effects on aggressiveness and anxiety in OF1 male mice
Redolat, R., G�mez, M. C., Vicens, P., & Carrasco, M. C. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1965-9 · Cited by 27
Sex heterogeneity in pharmacogenetic smoking cessation clinical trials
Schnoll, R. A., & Patterson, F. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.11.012 · Cited by 26
Can the blind see? Participant guess about treatment arm assignment may influence outcome in a clinical trial of bupropion for smoking cessation
Schnoll, R. A., Epstein, L. H., Audrain, J. E., NIAURA, R. S., Hawk, L. W., Shields, P. G., Lerman, C. E., & Wileyto, E. P. (2007) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2007.04.004 · Cited by 26
Self-citation
An update on therapeutics for tobacco dependence
Lancaster, T., Stead, L. F., & Cahill, K. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.1.15 · Cited by 26
Brain activity and emotional processing in smokers treated with varenicline
Loughead, J., Ray, R., Wileyto, E. P., Ruparel, K., O'Donnell, G. P., Senecal, N., Siegel, S. J., Gur, R. C., & Lerman, C. E. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00324.x · Cited by 24
Self-citation
Design, baseline characteristics, and retention of African American light smokers into a randomized trial involving biological data
Cox, L. S., Faseru, B., Mayo, M. S., Krebill, R., Snow, T. M., Bronars, C. A., Nollen, N. L., Choi, W. S., Okuyemi, K. S., Salzman, G. A., et al. (2011) · Trials · doi:10.1186/1745-6215-12-22 · Cited by 25

Authors: Lerman, C., Roth, D., Kaufmann, V., Audrain, J., Hawk, L., Liu, A., Niaura, R., & Epstein, L.
Affiliations: University of Pennsylvania Health System (US)
University of Alabama at Birmingham (US)
State University of New York (US)
Georgetown University (US)
University at Buffalo, State University of New York (US)
Corresponding author: Lerman, Caryn
ORCID: Lerman, Caryn
Roth, David
Hawk, Larry
Liu, Aiyi
Epstein, Leonard
Venue: Drug and Alcohol Dependence
Publisher: Elsevier BV
Published: 2002-07
Volume: 67
Issue: 2
Pages: 219-223
ISSN: 0376-8716 (ISSN-L)
DOI: 10.1016/s0376-8716(02)00067-4
OpenAlex: W2081438909
Cited by: 155
References: 18
Citations by year: 2026: 2 · 2025: 2 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 2 · 2020: 3 · 2019: 5 · 2018: 2 · 2017: 4 · 2016: 6 · 2015: 8 · 2014: 3 · 2013: 8 · 2012: 3
FWCI: 6.79
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Drug and Alcohol Dependence (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (P50CA084718, R01CA63562, P50-CA84718, R01CA063562)
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
Keywords: bupropion, smoking cessation, nicotine withdrawal symptoms, negative affect, positive affect, mediation analysis, behavioral counseling, nicotine dependence, abstinence
MeSH terms: Adult, Aged, Analysis of Variance, Female, Humans, Male, Middle Aged, Smoking, Smoking Cessation, Bupropion, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Mediating mechanisms for the impact of bupropion in smoking cessation treatment

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks